SEQUA Share Price Performance
€0.66
-0.26 (-28.06%)
Price €0.66
Share Pricen/a
Sequana Medical NV Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 7 Fair Values set on narratives written by author
SEQUA Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Sequana Medical NV Key Details
About SEQUA
- Founded
- 2006
- Employees
- 48
- CEO
- WebsiteView website
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally. The company offers alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body. Sequana Medical NV was founded in 2006 and is headquartered in Gent, Belgium.
